Aug 2026· International journal for advanced research in science & technology· Vol 15, pp. 2500-2504· 0 citations
TL;DR
KRS should be considered in adolescents with progressive cognitive decline and juvenile-onset parkinsonism, particularly when routine investigations are non-diagnostic, particularly when routine investigations are non-diagnostic.
Abstract
Background: Kufor–Rakeb syndrome (KRS) is a rare inherited neurodegenerative disorder caused by pathogenic variants in the ATP13A2 gene. It is characterised by juvenile-onset parkinsonism with progressive cognitive, neuropsychiatric, pyramidal, and bulbar manifestations.
Case Presentation: A 22-year-old boy presented with approximately 2.5 years of progressive cognitive and behavioural decline, followed by bulbar dysfunction and motor impairment. Symptoms began at 19.5 years of age with cognitive and behavioural changes; speech impairment and dysphagia developed during the subsequent months, and motor difficulties became prominent approximately one year after symptom onset. Neurological examination demonstrated cognitive impairment, hypomimia, generalised rigidity, dysarthria, brisk lower-limb deep tendon reflexes, and bilateral extensor plantar responses. Routine laboratory investigations and targeted metabolic and disease-specific evaluations were unrevealing. Clinical exome sequencing identified a homozygous pathogenic variant in the ATP13A2 gene, c.2629G>A (p.Gly877Arg), confirming KRS.
Conclusion: KRS should be considered in adolescents with progressive cognitive decline and juvenile-onset parkinsonism, particularly when routine investigations are non-diagnostic. Genetic testing is central to diagnosis and enables genetic counselling and multidisciplinary supportive care.
This case underscores that the genetic and neuropsychological identification of a neurodevelopmental disorder, together with the integration of tailored psychomotor interventions and contextual adaptations, can improve psychiatric management and daily functioning, and mitigate behavioral decline in adulthood, even foll...
A. Bos-Roubos, Rosalie Te Brinke, A. Kattentidt-Mouravieva et al.· Frontiers in Psychiatry· 0 citations
Rapid-onset dystonia-parkinsonism (RDP) is one of the best-known and most frequently encountered phenotypes of ATP1A3-associated disorders. It is characterized by acute or subacute onset of dystonia, parkinsonism, and bulbar symptoms, typically triggered by provoking factors such as fever, infections, or physical exert...
L. R. Zaripova, K. M. Evdokimov, Ksenia A. Gromova et al.· Annals of Clinical and Exper...· 0 citations
This case describes a previously unreported ELOVL4 frameshift variant in a patient with cerebellar ataxia, parkinsonism, severe cognitive impairment, and autonomic dysfunction, and genetic testing may facilitate differentiation of hereditary ataxia from atypical degenerative syndromes.
A 60-year-old patient presenting with progressive instability, late- ral propulsion, generalized polymyoclonus, tremors, paranoid delusions, paranoid delusions, and vivid hallucinations is reported, highlighting the value of DWI/MRI in identifying atypical variants and reinforces the importance of integrating biomarker...
Lussiana Folleco-Insuasty, C. Pantoja-Ruiz· 0 citations
Three patients with ATP1A3 variants who presented with initial acute encephalopathy, an unusual presentation, are described to draw clinicians' attention to this lesser-known clinical presentation.
C. Glasson, M. Gibaud, Marie Alesandrini et al.· Archives de pédiatrie· 0 citations
The case of a 23-year-old female with two likely pathogenic variants presumed to be in trans in PMPCB and a co-occurring pathogenic VCP variant, strong supporting a diagnosis of multiple mitochondrial dysfunctions syndrome 6, is described.
Reme Unuakhalu, Alexandra Purcell, Ishaan Jindal et al.· Molecular Genetics and Metab...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.